The Levels of Anaesthetics in Heart Muscle During Heart Surgery

NCT02471001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2016-11-28

No results posted yet for this study

Summary

In the last few years, anaesthetic agents, Isoflurane used in heart surgery have shown some benefits to reduce the risk of heart muscle damage. Many research studies have been conducted to reveal the benefit relationship between Isoflurane and the risk of heart muscle injury during heart surgery. However, there is a knowledge gap regarding the optimal level of Isoflurane concentration to confer the benefit of heart muscle-protective properties. Therefore, this study is conducted to answer that question by measuring the Isoflurane concentration in the blood vessels. It also assesses whether Isoflurane concentration in the blood is correlated to the oxygenator exhaust level of Isoflurane in the heart-lung machine.

Conditions

  • Cardiac Surgery

Interventions

BIOLOGICAL

Blood samples

Two additional blood samples will be taken from in-situ catheters during heart surgery.

Sponsors & Collaborators

  • NHS Lothian

    collaborator OTHER_GOV
  • University of Edinburgh

    lead OTHER

Principal Investigators

  • R Peter Alston, MB ChB · NHS Lothian

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471001 on ClinicalTrials.gov